This is the first in vivo and in vitro evidence that SDSS exerts its role in ameliorating arthritis through suppressing the HIF-1α/STAT3/NLRP3 pathway, therefore modulating the inflammatory activation in macrophages. The gene discussed is NLRP3; the disease is arthritic joint disease.